Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors

Organ transplantation is a life-saving procedure and the preferred method of treatment for a growing number of disease states. The advent of new immunosuppressants and improved care has led to great advances in both patient and graft survival. However, acute T-cell-mediated graft rejection occurs in...

Full description

Bibliographic Details
Main Authors: Kimberly S. Butler, Debbie M. Lovato, Natalie L. Adolphi, Robert Belfon, Danielle L. Fegan, Todd C. Monson, Helen J. Hathaway, Dale L. Huber, T. E. Tessier, H. C. Bryant, Edward R. Flynn, Richard S. Larson M.D., Ph.D.
Format: Article
Language:English
Published: SAGE Publishing 2013-10-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X657963
_version_ 1818969852265627648
author Kimberly S. Butler
Debbie M. Lovato
Natalie L. Adolphi
Robert Belfon
Danielle L. Fegan
Todd C. Monson
Helen J. Hathaway
Dale L. Huber
T. E. Tessier
H. C. Bryant
Edward R. Flynn
Richard S. Larson M.D., Ph.D.
author_facet Kimberly S. Butler
Debbie M. Lovato
Natalie L. Adolphi
Robert Belfon
Danielle L. Fegan
Todd C. Monson
Helen J. Hathaway
Dale L. Huber
T. E. Tessier
H. C. Bryant
Edward R. Flynn
Richard S. Larson M.D., Ph.D.
author_sort Kimberly S. Butler
collection DOAJ
description Organ transplantation is a life-saving procedure and the preferred method of treatment for a growing number of disease states. The advent of new immunosuppressants and improved care has led to great advances in both patient and graft survival. However, acute T-cell-mediated graft rejection occurs in a significant quantity of recipients and remains a life-threatening condition. Acute rejection is associated with decrease in long-term graft survival, demonstrating a need to carefully monitor transplant patients. Current diagnostic criteria for transplant rejection rely on invasive tissue biopsies or relatively nonspecific clinical features. A noninvasive way is needed to detect, localize, and monitor transplant rejection. Capitalizing on advances in targeted contrast agents and magnetic-based detection technology, we developed anti-CD3 antibody-tagged nanoparticles. T cells were found to bind preferentially to antibody-tagged nanoparticles, as identified through light microscopy, transmission electron microscopy, and confocal microscopy. Using mouse skin graft models, we were also able to demonstrate in vivo vascular delivery of T-cell targeted nanoparticles. We conclude that targeting lymphocytes with magnetic nanoparticles is conducive to developing a novel, noninvasive strategy for identifying transplant rejection.
first_indexed 2024-12-20T14:27:10Z
format Article
id doaj.art-145b2a46015d4263b09d28195e2adb03
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-20T14:27:10Z
publishDate 2013-10-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-145b2a46015d4263b09d28195e2adb032022-12-21T19:37:44ZengSAGE PublishingCell Transplantation0963-68971555-38922013-10-012210.3727/096368912X657963Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic SensorsKimberly S. Butler0Debbie M. Lovato1Natalie L. Adolphi2Robert Belfon3Danielle L. Fegan4Todd C. Monson5Helen J. Hathaway6Dale L. Huber7T. E. Tessier8H. C. Bryant9Edward R. Flynn10Richard S. Larson M.D., Ph.D.11Department of Pathology, University of New Mexico, and Cancer Research and Treatment Center, Albuquerque, NM, USADepartment of Pathology, University of New Mexico, and Cancer Research and Treatment Center, Albuquerque, NM, USADepartment of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, USADepartment of Cell Biology and Physiology, University of New Mexico, Albuquerque, NM, USASenior Scientific, LLC, Albuquerque, NM, USANanomaterials Sciences Department, Sandia National Laboratories, Albuquerque, NM, USADepartment of Cell Biology and Physiology, University of New Mexico, Albuquerque, NM, USACenter for Integrated Nanotechnologies, Sandia National Laboratories, Albuquerque, NM, USASenior Scientific, LLC, Albuquerque, NM, USASenior Scientific, LLC, Albuquerque, NM, USASenior Scientific, LLC, Albuquerque, NM, USADepartment of Pathology, University of New Mexico, and Cancer Research and Treatment Center, Albuquerque, NM, USAOrgan transplantation is a life-saving procedure and the preferred method of treatment for a growing number of disease states. The advent of new immunosuppressants and improved care has led to great advances in both patient and graft survival. However, acute T-cell-mediated graft rejection occurs in a significant quantity of recipients and remains a life-threatening condition. Acute rejection is associated with decrease in long-term graft survival, demonstrating a need to carefully monitor transplant patients. Current diagnostic criteria for transplant rejection rely on invasive tissue biopsies or relatively nonspecific clinical features. A noninvasive way is needed to detect, localize, and monitor transplant rejection. Capitalizing on advances in targeted contrast agents and magnetic-based detection technology, we developed anti-CD3 antibody-tagged nanoparticles. T cells were found to bind preferentially to antibody-tagged nanoparticles, as identified through light microscopy, transmission electron microscopy, and confocal microscopy. Using mouse skin graft models, we were also able to demonstrate in vivo vascular delivery of T-cell targeted nanoparticles. We conclude that targeting lymphocytes with magnetic nanoparticles is conducive to developing a novel, noninvasive strategy for identifying transplant rejection.https://doi.org/10.3727/096368912X657963
spellingShingle Kimberly S. Butler
Debbie M. Lovato
Natalie L. Adolphi
Robert Belfon
Danielle L. Fegan
Todd C. Monson
Helen J. Hathaway
Dale L. Huber
T. E. Tessier
H. C. Bryant
Edward R. Flynn
Richard S. Larson M.D., Ph.D.
Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
Cell Transplantation
title Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
title_full Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
title_fullStr Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
title_full_unstemmed Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
title_short Development of Antibody-Tagged Nanoparticles for Detection of Transplant Rejection Using Biomagnetic Sensors
title_sort development of antibody tagged nanoparticles for detection of transplant rejection using biomagnetic sensors
url https://doi.org/10.3727/096368912X657963
work_keys_str_mv AT kimberlysbutler developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT debbiemlovato developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT natalieladolphi developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT robertbelfon developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT daniellelfegan developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT toddcmonson developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT helenjhathaway developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT dalelhuber developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT tetessier developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT hcbryant developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT edwardrflynn developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors
AT richardslarsonmdphd developmentofantibodytaggednanoparticlesfordetectionoftransplantrejectionusingbiomagneticsensors